MICROBOT MEDICAL INC. Payments to Acquire Marketable Securities
MICROBOT MEDICAL INC. (MBOT) reported Payments to Acquire Marketable Securities of $1.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-11
- MICROBOT MEDICAL INC. payments to acquire marketable securities for the quarter ending 2026-06-30 was $629.00K, a 83.45% decline year-over-year.
- MICROBOT MEDICAL INC. payments to acquire marketable securities for the quarter ending 2026-03-31 was $441.00K, a 98.43% decline year-over-year.
- MICROBOT MEDICAL INC. payments to acquire marketable securities for the quarter ending 2025-06-30 was $3.80M.
- MICROBOT MEDICAL INC. payments to acquire marketable securities for the quarter ending 2025-03-31 was $28.12M.
- MICROBOT MEDICAL INC. payments to acquire marketable securities for fiscal 2023 was $10.06M, a 168.34% increase from fiscal 2022.
- MICROBOT MEDICAL INC. payments to acquire marketable securities for fiscal 2022 was $3.75M.
- MICROBOT MEDICAL INC. payments to acquire marketable securities for fiscal 2020 was $5.00M, a 100.24% increase from fiscal 2019.
- MICROBOT MEDICAL INC. payments to acquire marketable securities for fiscal 2019 was $2.50M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $629.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.07M 10-Q · filed 2026-08-11 | ||
| 2026-03-31 | $441.00K 10-Q · filed 2026-05-13 | |||
| 2025-06-30 | $3.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $31.92M 10-Q · filed 2026-08-11 | ||
| 2025-03-31 | $28.12M 10-Q · filed 2026-05-13 | |||
| 2023-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $6.87M derived: sum of 2 quarters · filed 2024-03-27 | $9.42M derived: sum of 3 quarters · filed 2024-03-27 | $10.06M 10-K · filed 2024-03-27 |
| 2023-09-30 | $5.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $7.74M derived: sum of 2 quarters · filed 2023-11-14 | $8.38M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $3.19M 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | $638.00K 10-Q · filed 2023-05-17 | |||
| 2022-12-31 | $3.75M 10-K · filed 2024-03-27 | |||
| 2020-12-31 | $5.00M 10-K · filed 2022-03-31 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $0.00 derived: sum of 3 quarters · filed 2021-03-31 | $2.50M 10-K · filed 2021-03-31 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $2.50M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $2.50M 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $2.50M 10-Q · filed 2020-05-15 | |||
| 2013-12-31 | $159.83K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $138.19K derived: sum of 2 quarters · filed 2016-03-15 | $216.41K derived: sum of 3 quarters · filed 2016-03-15 | $687.80K 10-K · filed 2016-03-15 |
| 2013-09-30 | -$21.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $56.58K derived: sum of 2 quarters · filed 2014-11-13 | $527.97K 10-Q · filed 2014-11-13 | $8.80M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | $78.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $549.60K 10-Q · filed 2014-08-12 | $8.82M derived: sum of 3 quarters · filed 2015-03-13 | $14.85M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | $471.39K 10-Q · filed 2014-05-14 | $8.74M derived: sum of 2 quarters · filed 2015-03-13 | $14.77M derived: sum of 3 quarters · filed 2015-03-13 | $14.78M derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-12-31 | $8.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $14.30M derived: sum of 2 quarters · filed 2015-03-13 | $14.30M derived: sum of 3 quarters · filed 2015-03-13 | $16.38M 10-K · filed 2015-03-13 |
| 2012-09-30 | $6.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $6.03M derived: sum of 2 quarters · filed 2013-11-05 | $8.11M 10-Q · filed 2013-11-05 | $8.07M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | $2.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $2.08M 10-Q · filed 2013-08-07 | $2.04M derived: sum of 3 quarters · filed 2014-03-13 | $2.54M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | $2.08M 10-Q · filed 2013-05-10 | $2.04M derived: sum of 2 quarters · filed 2014-03-13 | $2.54M derived: sum of 3 quarters · filed 2014-03-13 | $3.88M derived: sum of 4 quarters · filed 2014-03-13 |
| 2011-12-31 | -$35.67K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $462.95K derived: sum of 2 quarters · filed 2014-03-13 | $1.81M derived: sum of 3 quarters · filed 2014-03-13 | $10.19M 10-K · filed 2014-03-13 |
| 2011-09-30 | $498.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $1.84M derived: sum of 2 quarters · filed 2012-11-08 | $10.22M 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $9.73M 10-Q · filed 2012-08-08 | ||
| 2011-03-31 | $8.38M 10-Q · filed 2012-05-10 | |||
| 2009-12-31 | $4.98M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |